EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A pilot, randomized clinical trial: Left dorsolateral prefrontal cortex intermittent theta burst stimulation improves treatment outcomes in veterans with alcohol use disorder

Claudia B Padula iD, Daniel M McCalley iD, Lea-Tereza Tenekedjieva iD, Kelly MacNiven, Andrew Rauch iD, Jairelisse Morales Morales, Brian Knutson iD, Keith Humphreys, Leanne M Williams iD, Timothy C Durazzo iD

Alcohol: Clinical and Experimental Research · 2024-01 · 48 (1) · 164-177

DOI: 10.1111/acer.15224 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Alcohol: Clinical and Experimental Research, online erschienen am 10.01.2024. Verfasst von Claudia B Padula und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sierra Pacific Mental Illness Research Education and Clinical Center (MIRECC), Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, U…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Wu Tsai Neurosciences Institute, Stanford University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcranial magnetic stimulation (TMS) offers a promising treatment avenue to modulate brain function in alcohol use disorder (AUD). To the best of our knowledge, this pilot study is the first randomized, double‐blind, sham‐controlled trial to deliver intermittent theta burst stimulation to the left dorsolateral prefrontal cortex (DLPFC) among US veterans with AUD. We hypothesized that 20 sessions of real TMS are tolerable and feasible. As a secondary line of inquiry, we hypothesized that, relative to sham TMS, individuals receiving real TMS would experience greater reductions in 6‐month relapse rates, anhedonia, and alcohol cue‐reactivity.

Methods

Veterans ( n = 17, one woman) were enrolled in a double‐blind, sham‐controlled trial (2–3 sessions/day; 7–10 days; 600 pulses/session; 20 sessions). Pre‐ and posttreatment assessments included responses to self‐report questionnaires and functional magnetic resonance imaging measures of alcohol cue‐reactivity. Alcohol consumption was assessed for 6 months. Linear mixed‐effects models were constructed to predict posttreatment craving, mood, and cue‐reactivity.

Results

Individuals who received active iTBS ( n = 8) were less likely to relapse within 3 months after treatment than the sham‐treated group ( n = 9) (OR = 12.0). Greater reductions in anhedonia were observed following active iTBS (Cohen's d = −0.59), relative to sham ( d = −0.25). Alcohol cue‐reactivity was reduced following active iTBS and increased following sham within the left insula ( d = −0.19 vs. 0.51), left thalamus ( d = −0.28 vs. 0.77), right insula ( d = 0.18 vs. 0.52), and right thalamus ( d = −0.06 vs. 0.62).

Conclusions

Relative to sham, we demonstrate that 20 sessions of real left DLPFC iTBS reduced the likelihood of relapse for at least 3 months. The potential utility of this approach is underscored by observed decreases in anhedonia and alcohol cue‐reactivity—strong predictors of relapse among veterans. These initial data offer a valuable set of effect sizes to inform future clinical trials in this patient population.

Schlagwörter

Stichwörter der Autor:innen

alcohol use disorderanhedoniacue-reactivitytranscranial magnetic stimulationveterans

Autor:innen und Institutionen

  • Sierra Pacific Mental Illness Research Education and Clinical Center (MIRECC), Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
  • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Psychology, Stanford University, Stanford, California, USA.
  • Department of Psychology, Loyola University Chicago, Chicago, Illinois, USA.
  • Center for Innovation to Implementation, Veterans Affairs Palo Alto Healthcare System, Menlo Park, California, USA.

ORCID-Profile: Claudia B Padula, Daniel M McCalley, Lea-Tereza Tenekedjieva, Andrew Rauch, Brian Knutson, Leanne M Williams, Timothy C Durazzo

Förderung

  • Wu Tsai Neurosciences Institute, Stanford University

Zitieren

APA

Padula, C. B., McCalley, D. M., Tenekedjieva, L. T., MacNiven, K., Rauch, A., Morales, J. M., Knutson, B., Humphreys, K., Williams, L. M., & Durazzo, T. C. (2024). A pilot, randomized clinical trial: Left dorsolateral prefrontal cortex intermittent theta burst stimulation improves treatment outcomes in veterans with alcohol use disorder. Alcohol: Clinical and Experimental Research, 48(1), 164-177. https://doi.org/10.1111/acer.15224

Vancouver

Padula CB, McCalley DM, Tenekedjieva LT, MacNiven K, Rauch A, Morales JM, et al. A pilot, randomized clinical trial: Left dorsolateral prefrontal cortex intermittent theta burst stimulation improves treatment outcomes in veterans with alcohol use disorder. Alcohol: Clinical and Experimental Research. 2024;48(1):164-177. doi:10.1111/acer.15224

BibTeX
@article{Padula2024,
  author = {Padula, Claudia B and McCalley, Daniel M and Tenekedjieva, Lea-Tereza and MacNiven, Kelly and Rauch, Andrew and Morales, Jairelisse Morales and Knutson, Brian and Humphreys, Keith and Williams, Leanne M and Durazzo, Timothy C},
  title = {A pilot, randomized clinical trial: Left dorsolateral prefrontal cortex intermittent theta burst stimulation improves treatment outcomes in veterans with alcohol use disorder},
  journal = {Alcohol: Clinical and Experimental Research},
  year = {2024},
  volume = {48},
  number = {1},
  pages = {164--177},
  doi = {10.1111/acer.15224}
}
Kostenlos starten →